Marshall Wace North America’s Amneal Pharmaceuticals AMRX Stock Holding History

Marshall Wace North America’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$621K	Sell	116,469 -285,980	-71%	-$1.44M	﹤0.01%	1063
2021 Q2	$2.06M	Sell	402,449 -82,329	-17%	-$468K	0.01%	797
2021 Q1	$3.26M	Buy	484,778 +152,190	+46%	+$843K	0.01%	668
2020 Q4	$1.52M	Buy	+332,588	New	+$1.47M	0.01%	825
2020 Q2	–	Sell	-14,894	Closed	-$52K	–	1139
2020 Q1	$52K	Sell	14,894 -34,127	-70%	-$145K	﹤0.01%	1068
2019 Q4	$237K	Buy	+49,021	New	+$170K	﹤0.01%	940
2019 Q2	–	Sell	-66,512	Closed	-$942K	–	1126
2019 Q1	$942K	Buy	66,512 +31,063	+88%	+$411K	0.01%	679
2018 Q4	$480K	Buy	+35,449	New	+$639K	﹤0.01%	785

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace North America's AMRX Position: Q3 2021 in Review

Marshall Wace North America reduced its Amneal Pharmaceuticals (AMRX) stake by 71% in Q3 2021, selling an estimated $1.44M and leaving 116,469 shares worth $621K. The position accounts for ﹤0.01% of the portfolio, ranked #1063.

Marshall Wace North America first reported a position in AMRX in Q4 2018 and has held it in 8 quarters since. The position peaked at $3.26M in Q1 2021. 154 funds tracked by Wall St. Rank hold AMRX as of Q3 2021.

Marshall Wace North America held 116,469 shares of Amneal Pharmaceuticals worth $621K as of Q3 2021.
Marshall Wace North America sold 285,980 Amneal Pharmaceuticals shares in Q3 2021, an estimated $1.44M.
Amneal Pharmaceuticals made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1063 holding.
Marshall Wace North America first reported a position in Amneal Pharmaceuticals in Q4 2018 and has held it in 8 quarters since.
Marshall Wace North America's Amneal Pharmaceuticals position peaked at $3.26M in Q1 2021.
154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.